The UK became the first country in the world to grant emergency approval to a coronavirus vaccine created by the University of Oxford and British-Swedish multinational pharmaceutical company AstraZeneca. The vaccine’s trials had a rocky rollout and haven’t been known for transparency. But the University of Southampton’s Micheal Head tells The World’s Marco Werman that the vaccine’s approval is a game-changer in the fight against the coronavirus pandemic.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.